1	WASHINGTON	washington	NNP	_	32	npadvmod	32:AM-TMP
2	,	,	,	_	1	punct	_
3	May	may	NNP	_	1	appos	_
4	19	0	CD	_	3	num	_
5	,	,	,	_	32	punct	_
6	2014	0	CD	_	12	num	_
7	/	/	SYM	p2=,	12	punct	_
8	PRNewswire	prnewswire	NNP	p2=NN	12	nn	_
9	/	/	SYM	p2=NNPS	12	punct	_
10	--	--	:	_	12	punct	_
11	Spark	spark	NNP	p2=NN	12	nn	_
12	Therapeutics	therapeutics	NNP	p2=NNPS	32	nsubj	32:A0=PAG
13	,	,	,	_	12	punct	_
14	a	a	DT	_	18	det	_
15	late	late	JJ	_	17	hmod	_
16	-	-	HYPH	_	17	hyph	_
17	stage	stage	NN	_	18	nn	_
18	company	company	NN	_	12	appos	19:A0=PAG
19	developing	develop	VBG	pb=develop.02	18	partmod	_
20	gene	gene	NN	_	22	hmod	_
21	-	-	HYPH	_	22	hyph	_
22	based	base	VBN	_	23	amod	_
23	medicines	medicine	NNS	_	19	dobj	19:A1=PRD
24	for	for	IN	_	19	prep	_
25	a	a	DT	_	27	det	_
26	wide	wide	JJ	_	27	amod	_
27	range	range	NN	_	24	pobj	_
28	of	of	IN	_	27	prep	_
29	debilitating	debilitate	VBG	p2=NN|pb=debilitate.01	30	amod	_
30	diseases	disease	NNS	_	28	pobj	29:A0=PAG
31	,	,	,	_	12	punct	_
32	announced	announce	VBD	p2=VBN|pb=announce.01	0	root	_
33	today	today	NN	_	32	npadvmod	32:AM-TMP
34	that	that	IN	p2=DT	66	complm	_
35	co-founder	co-founder	NN	_	66	nsubj	66:A0=PAG
36	and	and	CC	_	35	cc	_
37	scientific	scientific	JJ	_	38	amod	_
38	advisor	advisor	NN	_	40	nn	_
39	Katherine	katherine	NNP	_	40	nn	_
40	High	high	NNP	_	35	conj	_
41	,	,	,	_	40	punct	_
42	M.D.	m.d.	NNP	p2=NN	40	appos	_
43	;	;	:	_	40	punct	_
44	co-founder	co-founder	NN	_	51	nn	_
45	,	,	,	_	44	punct	_
46	president	president	NN	_	44	conj	_
47	and	and	CC	_	46	cc	_
48	CEO	ceo	NN	p2=NNP	46	conj	_
49	Jeffrey	jeffrey	NNP	_	51	nn	_
50	D.	d.	NNP	_	51	nn	_
51	Marrazzo	marrazzo	NNP	_	40	conj	_
52	;	;	:	p2=,	32	punct	_
53	and	and	CC	_	35	cc	_
54	senior	senior	JJ	_	56	amod	_
55	vice	vice	NN	_	56	nn	_
56	president	president	NN	_	35	conj	_
57	of	of	IN	_	56	prep	_
58	business	business	NN	_	59	nn	_
59	development	development	NN	_	63	nn	_
60	Carol	carol	NNP	_	63	nn	_
61	Greve	greve	NNP	_	63	hmod	_
62	-	-	HYPH	_	63	hyph	_
63	Philips	philips	NNP	_	57	pobj	_
64	will	will	MD	_	66	aux	66:AM-MOD
65	each	each	DT	p2=VB	66	dep	_
66	present	present	VB	p2=JJ|pb=present.01	32	ccomp	32:A1=PPT
67	at	at	IN	_	66	prep	66:AM-LOC
68	the	the	DT	_	70	det	_
69	American	american	NNP	p2=JJ	70	nn	_
70	Society	society	NNP	_	78	poss	_
71	of	of	IN	_	70	prep	_
72	Gene	gene	NNP	_	71	pobj	_
73	&	&	CC	_	72	cc	_
74	Cell	cell	NNP	_	75	nn	_
75	Therapy	therapy	NNP	_	72	conj	_
76	's	's	POS	_	70	possessive	_
77	(	(	-LRB-	_	78	punct	_
78	ASGCT	asgct	NNP	p2=NN	67	pobj	_
79	)	)	-RRB-	_	78	punct	_
80	2014	0	CD	p2=NFP	82	num	_
81	Annual	annual	NNP	p2=NN	82	nn	_
82	Meeting	meeting	NNP	_	66	dobj	66:A1=PPT
83	.	.	.	_	32	punct	_

1	Spark	spark	NNP	p2=NN	3	poss	_
2	's	's	POS	_	1	possessive	_
3	team	team	NN	_	4	nsubj	4:A0=PAG
4	led	lead	VBD	pb=lead.02	0	root	_
5	the	the	DT	_	6	det	_
6	advancement	advancement	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	gene	gene	NN	_	9	nn	_
9	therapy	therapy	NN	_	10	nn	_
10	research	research	NN	_	7	pobj	_
11	for	for	IN	_	4	prep	4:AM-TMP
12	nearly	nearly	RB	_	13	advmod	_
13	two	#crd#	CD	_	14	num	_
14	decades	decade	NNS	_	11	pobj	_
15	-	-	:	p2=HYPH	14	punct	_
16	from	from	IN	_	14	prep	_
17	designing	designing	NN	p2=VBG	20	nn	_
18	and	and	CC	_	17	cc	_
19	manufacturing	manufacturing	NN	p2=VBG	17	conj	_
20	vectors	vector	NNS	_	16	pobj	_
21	to	to	IN	_	16	prep	_
22	conducting	conduct	VBG	pb=conduct.01	21	pcomp	_
23	studies	study	NNS	_	22	dobj	26:A0=CAU;22:A1=PPT
24	that	that	WDT	_	26	nsubj	26:R-A0
25	have	have	VBP	_	26	aux	_
26	shown	show	VBN	pb=show.01	23	rcmod	_
27	strong	strong	JJ	_	28	amod	_
28	potential	potential	NN	_	26	dobj	26:A1=PPT
29	for	for	IN	_	28	prep	_
30	safety	safety	NN	_	29	pobj	_
31	and	and	CC	_	30	cc	_
32	efficacy	efficacy	NN	p2=JJ	30	conj	_
33	,	,	,	_	26	punct	_
34	building	build	VBG	pb=build.01	26	advcl	_
35	a	a	DT	_	37	det	_
36	recognized	recognize	VBN	p2=JJ|pb=recognize.01	37	amod	_
37	center	center	NN	_	34	dobj	34:A1=PRD;36:A1=PPT
38	of	of	IN	_	37	prep	_
39	gene	gene	NN	_	40	nn	_
40	therapy	therapy	NN	_	41	nn	_
41	innovation	innovation	NN	_	38	pobj	_
42	in	in	IN	_	37	prep	_
43	research	research	NN	_	42	pobj	_
44	,	,	,	_	43	punct	_
45	translation	translation	NN	_	43	conj	_
46	and	and	CC	_	45	cc	_
47	manufacturing	manufacturing	NN	_	45	conj	_
48	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	3:A0=PAG;18:A0=PAG
3	has	have	VBZ	pb=have.03	0	root	_
4	a	a	DT	_	6	det	_
5	robust	robust	JJ	_	6	amod	_
6	pipeline	pipeline	NN	_	3	dobj	3:A1=PPT
7	of	of	IN	_	6	prep	_
8	clinical	clinical	JJ	_	13	amod	_
9	and	and	CC	_	8	cc	_
10	preclinical	preclinical	JJ	_	8	conj	_
11	gene	gene	NN	_	12	nn	_
12	therapy	therapy	NN	_	13	nn	_
13	programs	program	NNS	_	7	pobj	_
14	,	,	,	_	3	punct	_
15	and	and	CC	_	3	cc	_
16	is	be	VBZ	_	18	aux	_
17	currently	currently	RB	_	18	advmod	18:AM-TMP
18	advancing	advance	VBG	pb=advance.01	3	conj	_
19	the	the	DT	_	26	det	_
20	only	only	JJ	p2=RB	22	amod	_
21	ongoing	ongoing	JJ	_	22	amod	_
22	Phase	phase	NN	p2=NNP	26	nn	_
23	3	0	CD	_	26	num	_
24	gene	gene	NN	_	25	nn	_
25	therapy	therapy	NN	_	26	nn	_
26	study	study	NN	_	18	dobj	18:A1=PPT
27	in	in	IN	_	26	prep	_
28	the	the	DT	_	29	det	_
29	U.S.	u.s.	NNP	_	27	pobj	_
30	to	to	TO	_	31	aux	_
31	address	address	VB	pb=address.02	26	infmod	_
32	inherited	inherit	VBN	pb=inherit.01	34	amod	_
33	retinal	retinal	JJ	p2=VB	34	amod	_
34	dystrophies	dystrophy	NNS	p2=NN	31	dobj	31:A1=PPT;32:A1=PPT;35:A1=PPT
35	caused	cause	VBN	pb=cause.01	34	partmod	_
36	by	by	IN	_	35	agent	35:A0=CAU
37	mutations	mutation	NNS	_	36	pobj	_
38	of	of	IN	_	37	prep	_
39	the	the	DT	_	41	det	_
40	RPE65	rpe65	NNP	p2=NN	41	nn	_
41	gene	gene	NN	_	38	pobj	_
42	.	.	.	_	3	punct	_

1	Katherine	katherine	NNP	_	2	nn	_
2	High	high	NNP	_	6	npadvmod	6:AM-DIS
3	,	,	,	_	6	punct	_
4	M.D.	m.d.	NNP	_	6	nsubj	6:A0=PAG
5	will	will	MD	_	6	aux	6:AM-MOD
6	present	present	VB	p2=JJ|pb=present.01	0	root	_
7	"	"	``	_	9	punct	_
8	Gene	gene	NNP	_	9	nn	_
9	Therapy	therapy	NNP	_	6	dobj	6:A1=PPT
10	for	for	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	Hemophilias	hemophilia	NNPS	p2=NNP	10	pobj	_
13	,	,	,	_	9	punct	_
14	"	"	''	p2=``	9	punct	_
15	as	as	IN	_	6	prep	6:AM-PNC
16	part	part	NN	_	15	pobj	_
17	of	of	IN	_	16	prep	_
18	the	the	DT	_	21	det	_
19	ASGCT	asgct	NNP	_	21	nn	_
20	Scientific	scientific	NNP	_	21	nn	_
21	Symposium	symposium	NNP	_	9	appos	_
22	104	0	CD	_	21	num	_
23	:	:	:	_	47	punct	_
24	Gene	gene	NNP	_	32	nn	_
25	&	&	CC	_	24	cc	_
26	Cell	cell	NNP	_	27	nn	_
27	Therapy	therapy	NNP	_	24	conj	_
28	of	of	IN	_	27	prep	_
29	Genetic	genetic	NNP	_	28	pobj	_
30	and	and	CC	_	27	cc	_
31	Metabolic	metabolic	NNP	p2=JJ	27	conj	_
32	Diseases	diseases	NNP	p2=NNPS	21	appos	_
33	at	at	IN	_	32	prep	_
34	8:30	0	CD	_	36	num	_
35	AM	am	NNP	p2=NN	36	nn	_
36	ET	et	NNP	_	33	pobj	_
37	on	on	IN	_	32	prep	_
38	Wednesday	wednesday	NNP	_	37	pobj	_
39	,	,	,	_	38	punct	_
40	May	may	NNP	_	47	dep	_
41	21	0	CD	_	40	num	_
42	,	,	,	_	40	punct	_
43	2014	0	CD	_	40	num	_
44	,	,	,	_	32	punct	_
45	in	in	IN	_	24	prep	_
46	Washington	washington	NNP	_	45	pobj	_
47	4	0	CD	_	46	num	_
48	at	at	IN	_	47	prep	_
49	the	the	DT	_	52	det	_
50	Marriott	marriott	NNP	_	52	nn	_
51	Wardman	wardman	NNP	_	52	nn	_
52	Park	park	NNP	_	48	pobj	_
53	in	in	IN	_	52	prep	_
54	Washington	washington	NNP	_	53	pobj	_
55	,	,	,	_	54	punct	_
56	DC	dc	NNP	_	54	appos	_
57	.	.	.	_	6	punct	_

1	Kathy	kathy	NNP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	dedicated	dedicate	VBN	pb=dedicate.01	0	root	_
4	her	her	PRP$	p2=PRP	5	poss	_
5	career	career	NN	_	3	dobj	3:A1=PPT
6	to	to	IN	_	3	prep	3:A2=GOL
7	unraveling	unravel	VBG	pb=unravel.01	6	pcomp	_
8	the	the	DT	_	10	det	_
9	molecular	molecular	JJ	_	10	amod	_
10	basis	basis	NN	_	7	dobj	7:A1=PPT
11	of	of	IN	_	10	prep	_
12	hemophilia	hemophilia	NN	p2=NNS	11	pobj	_
13	and	and	CC	_	12	cc	_
14	her	her	PRP$	_	16	poss	_
15	pioneering	pioneer	VBG	p2=JJ|pb=pioneer.01	16	amod	_
16	work	work	NN	_	12	conj	15:A1=GOL
17	to	to	TO	_	18	aux	_
18	develop	develop	VB	pb=develop.02	7	advcl	_
19	gene	gene	NN	_	20	nn	_
20	therapy	therapy	NN	_	18	dobj	18:A1=PRD
21	as	as	IN	_	18	prep	_
22	a	a	DT	_	23	det	_
23	treatment	treatment	NN	_	21	pobj	_
24	for	for	IN	_	23	prep	_
25	the	the	DT	_	26	det	_
26	disease	disease	NN	_	24	pobj	27:A0=PAG
27	led	lead	VBD	p2=VBN|pb=lead.03	26	partmod	_
28	to	to	IN	_	27	prep	27:A2=PRD
29	the	the	DT	_	30	det	_
30	advancement	advancement	NN	_	28	pobj	_
31	of	of	IN	_	30	prep	_
32	new	new	JJ	_	34	amod	_
33	treatment	treatment	NN	_	34	nn	_
34	modalities	modality	NNS	_	31	pobj	_
35	.	.	.	_	3	punct	_

1	Jeffrey	jeffrey	NNP	_	3	nn	_
2	D.	d.	NNP	_	3	nn	_
3	Marrazzo	marrazzo	NNP	_	5	nsubj	5:A0=PAG
4	will	will	MD	_	5	aux	5:AM-MOD
5	participate	participate	VB	pb=participate.01	0	root	_
6	in	in	IN	_	5	prep	5:A1=PPT
7	a	a	DT	_	9	det	_
8	panel	panel	NN	_	9	nn	_
9	discussion	discussion	NN	_	6	pobj	11:A0=PAG
10	that	that	WDT	p2=IN	11	nsubj	11:R-A0
11	illuminates	illuminate	VBZ	pb=illuminate.01	9	rcmod	_
12	the	the	DT	_	13	det	_
13	path	path	NN	_	11	dobj	11:A1=GOL
14	to	to	TO	_	15	aux	_
15	translate	translate	VB	pb=translate.01	13	infmod	_
16	groundbreaking	groundbreaking	VBG	p2=JJ|pb=groundbreaking.01	15	xcomp	15:A1=PPT
17	scientific	scientific	JJ	_	18	amod	_
18	discoveries	discovery	NNS	_	16	dobj	16:A1
19	into	into	IN	_	16	prep	16:A2
20	effective	effective	JJ	_	21	amod	_
21	treatments	treatment	NNS	_	19	pobj	_
22	for	for	IN	_	21	prep	_
23	patients	patient	NNS	_	22	pobj	_
24	.	.	.	_	5	punct	_

1	Topics	topic	NNS	p2=NN	4	nsubj	4:A2=GOL
2	for	for	IN	_	1	prep	_
3	discussion	discussion	NN	_	2	pobj	_
4	include	include	VBP	pb=include.01	0	root	_
5	sources	source	NNS	_	4	dobj	4:A1=PPT
6	of	of	IN	_	5	prep	_
7	funding	funding	NN	_	6	pobj	_
8	to	to	TO	p2=IN	9	aux	_
9	support	support	VB	pb=support.01	4	advcl	_
10	translational	translational	JJ	p2=DT	11	amod	_
11	research	research	NN	_	9	dobj	9:A1
12	,	,	,	_	11	punct	_
13	clinical	clinical	JJ	_	14	amod	_
14	development	development	NN	_	15	nn	_
15	needs	need	NNS	p2=VBZ	11	conj	_
16	,	,	,	_	15	punct	_
17	licensing	licensing	NN	p2=VBG	18	nn	_
18	products	product	NNS	_	15	conj	_
19	under	under	IN	_	18	prep	_
20	development	development	NN	_	19	pobj	_
21	,	,	,	_	18	punct	_
22	and	and	CC	_	18	cc	_
23	partnership	partnership	NN	_	24	nn	_
24	considerations	consideration	NNS	_	18	conj	_
25	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	panel	panel	NN	_	5	nsubj	_
3	,	,	,	_	21	punct	_
4	"	"	``	p2=''	5	punct	_
5	Perspective	perspective	JJ	p2=NNP	21	ccomp	_
6	from	from	IN	_	5	prep	_
7	Private	private	NNP	p2=JJ	9	amod	_
8	Sector	sector	NNP	_	9	nn	_
9	Leaders	leader	NNS	p2=NNPS	6	pobj	_
10	:	:	:	_	21	punct	_
11	What	what	WP	_	13	dobj	13:R-A1
12	We	we	PRP	_	13	nsubj	13:A0=PAG
13	Have	have	VBP	pb=have.03	21	advcl	_
14	and	and	CC	_	13	cc	_
15	What	what	WP	_	17	dobj	17:R-A1
16	We	we	PRP	_	17	nsubj	17:A0=PAG
17	Need	need	VBP	pb=need.01	13	conj	_
18	,	,	,	_	21	punct	_
19	"	"	''	p2=``	21	punct	_
20	will	will	MD	_	21	aux	21:AM-MOD
21	take	take	VB	pb=take.14	0	root	_
22	place	place	NN	_	21	dobj	21:A2
23	at	at	IN	_	21	prep	21:AM-TMP
24	7:30	0	CD	_	25	num	_
25	PM	pm	NN	p2=NNP	23	pobj	_
26	ET	et	NNP	p2=NN	25	appos	_
27	on	on	IN	_	21	prep	21:AM-TMP
28	Wednesday	wednesday	NNP	_	27	pobj	_
29	,	,	,	_	28	punct	_
30	May	may	NNP	_	28	appos	_
31	21	0	CD	_	30	num	_
32	,	,	,	_	30	punct	_
33	2014	0	CD	_	30	num	_
34	in	in	IN	_	30	prep	_
35	Delaware	delaware	NNP	_	36	nn	_
36	AB	ab	NNP	_	34	pobj	_
37	at	at	IN	_	30	prep	_
38	the	the	DT	_	41	det	_
39	Marriott	marriott	NNP	_	41	nn	_
40	Wardman	wardman	NNP	_	41	nn	_
41	Park	park	NNP	_	37	pobj	_
42	in	in	IN	_	41	prep	_
43	Washington	washington	NNP	_	42	pobj	_
44	,	,	,	_	43	punct	_
45	DC	dc	NNP	_	43	appos	_
46	.	.	.	_	21	punct	_

1	Carol	carol	NNP	p2=VB	4	nn	_
2	Greve	greve	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	Philips	philips	NNP	_	6	nsubj	6:A0=PAG;13:A0=PAG
5	will	will	MD	_	6	aux	6:AM-MOD
6	present	present	VB	pb=present.01	0	root	_
7	her	her	PRP$	p2=PRP	8	poss	_
8	talk	talk	NN	p2=VB	6	dobj	6:A1=PPT
9	,	,	,	_	6	punct	_
10	"	"	''	p2=``	11	punct	_
11	Hemophilia	hemophilia	NNP	p2=XX	8	appos	_
12	:	:	:	_	11	punct	_
13	Building	build	VBG	p2=NNP|pb=build.01	6	advcl	_
14	the	the	DT	_	16	det	_
15	Business	business	NN	p2=NNP	16	nn	_
16	Cases	case	NNS	p2=NNPS	13	dobj	13:A1=PRD
17	for	for	IN	_	16	prep	_
18	Multiple	multiple	NNP	p2=JJ	19	nn	_
19	Entrants	entrants	NNP	p2=NNPS	17	pobj	_
20	,	,	,	_	13	punct	_
21	"	"	``	p2=''	13	punct	_
22	at	at	IN	_	11	prep	_
23	3:40	0	CD	_	24	num	_
24	PM	pm	NN	p2=NNP	22	pobj	_
25	ET	et	NNP	p2=NN	24	appos	_
26	on	on	IN	_	25	prep	_
27	Tuesday	tuesday	NNP	_	26	pobj	_
28	,	,	,	_	25	punct	_
29	May	may	NNP	_	36	dep	_
30	20	0	CD	_	29	num	_
31	,	,	,	_	29	punct	_
32	2014	0	CD	_	29	num	_
33	,	,	,	_	6	punct	_
34	in	in	IN	_	1	prep	_
35	Washington	washington	NNP	_	34	pobj	_
36	4	0	CD	_	35	num	_
37	at	at	IN	_	36	prep	_
38	the	the	DT	_	41	det	_
39	Marriott	marriott	NNP	_	41	nn	_
40	Wardman	wardman	NNP	_	41	nn	_
41	Park	park	NNP	_	37	pobj	_
42	in	in	IN	_	41	prep	_
43	Washington	washington	NNP	_	42	pobj	_
44	,	,	,	_	43	punct	_
45	DC	dc	NNP	_	43	appos	_
46	.	.	.	_	6	punct	_

1	Carol	carol	NNP	p2=NN	3	nsubj	3:A0=PAG;13:A0=PAG
2	previously	previously	RB	_	3	advmod	3:AM-TMP
3	served	serve	VBD	pb=serve.01	0	root	_
4	as	as	IN	_	3	prep	3:A1=PPT
5	vice	vice	NN	_	6	nn	_
6	president	president	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	corporate	corporate	JJ	_	9	amod	_
9	development	development	NN	_	7	pobj	_
10	at	at	IN	_	6	prep	_
11	Genzyme	genzyme	NNP	p2=NN	10	pobj	_
12	and	and	CC	_	3	cc	_
13	brings	bring	VBZ	pb=bring.01	3	conj	_
14	more	more	JJR	_	16	amod	_
15	than	than	IN	_	16	quantmod	_
16	15	0	CD	_	17	num	_
17	years	year	NNS	_	13	dobj	13:A1=PPT
18	of	of	IN	_	17	prep	_
19	perspective	perspective	NN	_	18	pobj	_
20	on	on	IN	_	19	prep	_
21	the	the	DT	_	24	det	_
22	unique	unique	JJ	_	24	amod	_
23	market	market	NN	_	24	nn	_
24	dynamics	dynamic	NNS	p2=NN	20	pobj	25:A1=PPT
25	associated	associate	VBN	pb=associate.01	24	partmod	_
26	with	with	IN	_	25	prep	25:A2=PPT
27	small	small	JJ	_	29	amod	_
28	patient	patient	JJ	p2=NN	29	amod	_
29	populations	population	NNS	_	26	pobj	_
30	.	.	.	_	3	punct	_

1	Spark	spark	NNP	p2=NN	2	nn	_
2	Therapeutics	therapeutics	NNP	p2=NNPS	4	nsubj	4:A0=PAG
3	is	be	VBZ	_	4	aux	_
4	developing	develop	VBG	pb=develop.02	0	root	_
5	potentially	potentially	RB	_	6	advmod	_
6	curative	curative	JJ	_	13	amod	_
7	,	,	,	_	13	punct	_
8	one	#crd#	CD	_	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	time	time	NN	_	13	nn	_
11	gene	gene	NN	_	12	nn	_
12	therapy	therapy	NN	_	13	nn	_
13	products	product	NNS	_	4	dobj	4:A1=PRD
14	to	to	TO	_	15	aux	_
15	transform	transform	VB	pb=transform.01	13	infmod	_
16	the	the	DT	_	17	det	_
17	lives	life	NNS	_	15	dobj	15:A1=PPT
18	of	of	IN	_	17	prep	_
19	patients	patient	NNS	_	18	pobj	_
20	and	and	CC	_	15	cc	_
21	re-imagine	re-imagine	VB	p2=VBP|pb=re-imagine.01	15	conj	_
22	the	the	DT	_	23	det	_
23	treatment	treatment	NN	_	21	dobj	21:A1
24	of	of	IN	_	23	prep	_
25	debilitating	debilitate	VBG	p2=NN|pb=debilitate.01	24	pcomp	_
26	diseases	disease	NNS	_	25	dobj	25:A1=PPT
27	.	.	.	_	4	punct	_

1	Spark	spark	NNP	p2=VB	6	poss	_
2	's	's	POS	_	1	possessive	_
3	lead	lead	JJ	p2=NN	6	amod	_
4	gene	gene	NN	_	5	nn	_
5	therapy	therapy	NN	_	6	nn	_
6	candidate	candidate	NN	_	14	nsubj	14:A1=PPT
7	,	,	,	_	6	punct	_
8	for	for	IN	_	6	prep	_
9	RPE65	rpe0	NN	p2=NNP	11	hmod	_
10	-	-	HYPH	_	11	hyph	_
11	related	relate	VBN	_	12	amod	_
12	blindness	blindness	NN	_	8	pobj	_
13	,	,	,	_	14	punct	_
14	is	be	VBZ	pb=be.01	0	root	_
15	currently	currently	RB	_	14	advmod	14:AM-TMP
16	in	in	IN	_	14	prep	14:A2=PRD
17	Phase	phase	NNP	p2=NN	16	pobj	_
18	3	0	CD	_	17	num	_
19	clinical	clinical	JJ	_	20	amod	_
20	trials	trial	NNS	_	17	appos	_
21	with	with	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	potential	potential	NN	_	21	pobj	_
24	to	to	TO	_	25	aux	_
25	be	be	VB	pb=be.01	23	infmod	_
26	the	the	DT	_	30	det	_
27	first	#ord#	JJ	_	30	amod	_
28	approved	approve	VBN	p2=JJ|pb=approve.01	30	amod	_
29	gene	gene	NN	_	30	nn	_
30	therapy	therapy	NN	_	25	attr	28:A1=PPT;25:A2=PRD
31	in	in	IN	_	30	prep	_
32	the	the	DT	_	33	det	_
33	U.S.	u.s.	NNP	_	31	pobj	_
34	,	,	,	_	20	punct	_
35	and	and	CC	_	20	cc	_
36	the	the	DT	_	38	det	_
37	first	#ord#	JJ	_	38	amod	_
38	treatment	treatment	NN	_	20	conj	_
39	to	to	TO	_	40	aux	_
40	address	address	VB	pb=address.02	38	infmod	_
41	the	the	DT	_	44	det	_
42	significant	significant	JJ	_	44	amod	_
43	unmet	unmet	JJ	p2=NN	44	amod	_
44	needs	need	NNS	_	40	dobj	40:A1=PPT
45	of	of	IN	_	44	prep	_
46	patients	patient	NNS	_	45	pobj	47:A0=PAG
47	living	live	VBG	pb=live.01	46	partmod	_
48	with	with	IN	_	47	prep	47:AM-MNR
49	blindness	blindness	NN	_	48	pobj	_
50	due	due	IN	p2=JJ	49	prep	_
51	to	to	IN	_	50	pcomp	_
52	inherited	inherit	VBN	pb=inherit.01	54	amod	_
53	retinal	retinal	JJ	p2=NN	54	amod	_
54	dystrophies	dystrophy	NNS	p2=NN	50	pobj	52:A1=PPT
55	.	.	.	_	14	punct	_

1	The	the	DT	_	3	det	_
2	American	american	NNP	p2=JJ	3	nn	_
3	Society	society	NNP	_	12	nsubj	12:A1=PPT
4	of	of	IN	_	3	prep	_
5	Gene	gene	NNP	_	4	pobj	_
6	&	&	CC	_	5	cc	_
7	Cell	cell	NNP	_	8	nn	_
8	Therapy	therapy	NNP	_	5	conj	_
9	(	(	-LRB-	_	3	punct	_
10	ASGCT	asgct	NNP	_	3	appos	_
11	)	)	-RRB-	_	3	punct	_
12	is	be	VBZ	pb=be.01	0	root	_
13	a	a	DT	_	19	det	_
14	professional	professional	JJ	_	19	amod	_
15	nonprofit	nonprofit	JJ	p2=NN	19	amod	_
16	medical	medical	JJ	_	19	amod	_
17	and	and	CC	_	16	cc	_
18	scientific	scientific	JJ	_	16	conj	_
19	organization	organization	NN	_	12	attr	20:A1=PPT;12:A2=PRD
20	dedicated	dedicate	VBN	pb=dedicate.01	19	partmod	_
21	to	to	IN	_	20	prep	20:A2=GOL
22	the	the	DT	_	23	det	_
23	understanding	understanding	NN	_	21	pobj	_
24	,	,	,	_	23	punct	_
25	development	development	NN	_	23	conj	_
26	and	and	CC	_	25	cc	_
27	application	application	NN	_	25	conj	_
28	of	of	IN	_	23	prep	_
29	genetic	genetic	JJ	_	32	amod	_
30	and	and	CC	_	29	cc	_
31	cellular	cellular	JJ	_	29	conj	_
32	therapies	therapy	NNS	_	28	pobj	_
33	and	and	CC	_	23	cc	_
34	the	the	DT	_	35	det	_
35	promotion	promotion	NN	_	23	conj	_
36	of	of	IN	_	35	prep	_
37	professional	professional	JJ	_	40	amod	_
38	and	and	CC	_	37	cc	_
39	public	public	JJ	_	37	conj	_
40	education	education	NN	_	36	pobj	_
41	in	in	IN	_	35	prep	_
42	the	the	DT	_	43	det	_
43	field	field	NN	_	41	pobj	_
44	.	.	.	_	12	punct	_

1	For	for	IN	_	7	prep	7:AM-PRP
2	more	more	JJR	_	3	amod	_
3	information	information	NN	_	1	pobj	_
4	on	on	IN	_	3	prep	_
5	ASGCT	asgct	NNP	p2=NN	4	pobj	_
6	,	,	,	_	7	punct	_
7	visit	visit	VB	pb=visit.01	0	root	_
8	its	its	PRP$	_	9	poss	_
9	website	website	NN	_	7	dobj	7:A1=COM
10	,	,	,	_	9	punct	_
11	www.asgct.org	#url#	ADD	_	9	appos	_
12	.	.	.	_	7	punct	_

